SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-017947
Filing Date
2019-09-13
Accepted
2019-09-13 14:56:54
Documents
4
Period of Report
2019-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k090919_bioxytraninc.htm 8-K 35136
2 FORM OF ADVISORY BOARD AGREEMENT BETWEEN BIOXYTRAN, INC. AND JONATHAN JENSEN DAT f8k090919ex10-28_bioxytran.htm EX-10.28 41213
3 FORM OF ADVISORY BOARD AGREEMENT BETWEEN BIOXYTRAN, INC. AND PATRICK HUDDIE DATE f8k090919ex10-29_bioxytran.htm EX-10.29 40290
4 PRESS RELEASE DATED SEPTEMBER 16, 2019 f8k090919ex99-1_bioxytran.htm EX-99.1 12639
  Complete submission text file 0001213900-19-017947.txt   130790
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 191092410
SIC: 2834 Pharmaceutical Preparations